Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple supplement safely boost brain health in early memory loss?

NCT ID NCT07583251

Recruiting now Symptom relief Sponsor: Pravat Mandal Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study is testing whether a supplement called gamma glutamylcysteine (GGC) is safe for people with mild cognitive impairment (MCI), a condition that can lead to memory loss. Nine volunteers aged 55 to 80 will take different doses of GGC daily for three months. Researchers will monitor for side effects and check blood levels of key substances to see if the supplement might help the body's natural defenses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD COGNITIVE IMPAIRMENT (MCI)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UPMC Presbyterian Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.